c-Cbl is tyrosine-phosphorylated by interleukin-4 and enhances mitogenic and survival signals of interleukin-4 receptor by linking with the phosphatidylinositol 3'-kinase pathway
- PMID: 9414268
c-Cbl is tyrosine-phosphorylated by interleukin-4 and enhances mitogenic and survival signals of interleukin-4 receptor by linking with the phosphatidylinositol 3'-kinase pathway
Abstract
Interleukin-4 (IL-4) is a cytokine that induces both proliferation and differentiation and suppresses apoptosis of B cells. Although IL-4 has been shown to activate the phosphatidylinositol 3' (PI3)-kinase pathway, the role of PI3 kinase in the IL-4 receptor (IL-4R) signaling remains unclear. In this study, we demonstrated that c-Cbl proto-oncogene product is inducibly phosphorylated on tyrosine residues and is associated with the p85 subunit of PI3-kinase by IL-4 stimulation. Overexpression of c-Cbl enhances the PI3-kinase activity and, at the same time, mitogenic activity and survival of cells in the presence of IL-4. However, these effects of c-Cbl were abolished by wortmannin, a specific inhibitor for the PI3 kinase pathway, or by a point mutation at tyrosine 731 of c-Cbl, which is a major binding site for p85. These results indicate that c-Cbl plays a role in linking IL-4R with the PI3 kinase pathway and thus enhancing the mitogenic and survival signals.
Similar articles
-
The phosphatidylinositol 3' kinase pathway is required for the survival signal of leukocyte tyrosine kinase.Oncogene. 1997 Jun 26;14(25):3067-72. doi: 10.1038/sj.onc.1201153. Oncogene. 1997. PMID: 9223670
-
Interleukin-4 induces association of the c-fes proto-oncogene product with phosphatidylinositol-3 kinase.Blood. 1996 Nov 15;88(10):3910-8. Blood. 1996. PMID: 8916957
-
CD38-mediated growth suppression of B-cell progenitors requires activation of phosphatidylinositol 3-kinase and involves its association with the protein product of the c-cbl proto-oncogene.Blood. 1996 Jul 15;88(2):590-8. Blood. 1996. PMID: 8695807
-
Specific association of the beta isoform of the p85 subunit of phosphatidylinositol-3 kinase with the proto-oncogene c-cbl.J Biol Chem. 1995 Aug 4;270(31):18260-3. doi: 10.1074/jbc.270.31.18260. J Biol Chem. 1995. PMID: 7629144
-
Advances in the previous two decades in our understanding of the post-translational modifications, functions, and drug perspectives of ArgBP2 and its family members.Biomed Pharmacother. 2022 Nov;155:113853. doi: 10.1016/j.biopha.2022.113853. Epub 2022 Oct 8. Biomed Pharmacother. 2022. PMID: 36271588 Review.
Cited by
-
Cbl-b positively regulates Btk-mediated activation of phospholipase C-gamma2 in B cells.J Exp Med. 2002 Jul 1;196(1):51-63. doi: 10.1084/jem.20020068. J Exp Med. 2002. PMID: 12093870 Free PMC article.
-
c-Cbl acts as a mediator of Src-induced activation of the PI3K-Akt signal transduction pathway during TRAIL treatment.Cell Signal. 2010 Mar;22(3):377-85. doi: 10.1016/j.cellsig.2009.10.007. Cell Signal. 2010. PMID: 19861161 Free PMC article.
-
Loss of Cbl-b increases osteoclast bone-resorbing activity and induces osteopenia.J Bone Miner Res. 2009 Jul;24(7):1162-72. doi: 10.1359/jbmr.090205. J Bone Miner Res. 2009. PMID: 19257814 Free PMC article.
-
Roles of E3 ubiquitin ligases in cell adhesion and migration.Cell Adh Migr. 2010 Jan-Mar;4(1):10-8. doi: 10.4161/cam.4.1.9834. Epub 2010 Jan 18. Cell Adh Migr. 2010. PMID: 20009572 Free PMC article. Review.
-
Loss of Cbl-PI3K interaction modulates the periosteal response to fracture by enhancing osteogenic commitment and differentiation.Bone. 2017 Feb;95:124-135. doi: 10.1016/j.bone.2016.11.020. Epub 2016 Nov 22. Bone. 2017. PMID: 27884787 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous
